Chlorpromazine Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Chlorpromazine Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING

WARNING

WARNINGS

CHLORPROMAZINE HYDROCHLORIDE DESCRIPTION


Chlorpromazine Hydrochloride




CLINICAL PHARMACOLOGY



INDICATIONS & USAGE











CHLORPROMAZINE HYDROCHLORIDE CONTRAINDICATIONS




WARNINGS

Increased Mortality in Elderly Patients with Dementia-Related Psychosis
BOXED WARNING
The extrapyramidal symptoms which can occur secondary to chlorpromazine may be confused with the central nervous system signs of an undiagnosed primary disease responsible for the vomiting, e.g., Reye's syndrome or other encephalopathy. The use of chlorpromazine and other potential hepatotoxins should be avoided in children and adolescents whose signs and symptoms suggest Reye's syndrome.

Tardive Dyskinesia:




PRECAUTIONSADVERSE REACTIONS

Neuroleptic Malignant Syndrome (NMS):









Usage in Pregnancy:


Non-teratogenic Effects:


Nursing Mothers:

PRECAUTIONS

Leukopenia, Neutropenia and Agranulocytosis




General





Note:notnot











Long-Term Therapy:

Antiemetic Effect:WARNINGS


Abrupt Withdrawal:

CHLORPROMAZINE HYDROCHLORIDE ADVERSE REACTIONS

Note:

Drowsiness:

Jaundice:




Hematological Disorders:

Agranulocytosis



Cardiovascular:

Hypotensive Effects


EKG Changes
Note:

CNS Reactions:



Dystonia
Class effect

Motor Restlessness:


Pseudoparkinsonism:

Tardive Dyskinesia:



Adverse Behavioral Effects

Other CNS EffectsWARNINGS




Allergic Reactions



Endocrine Disorders:

Autonomic Reactions:

Special Considerations In Long-Term Therapy

Skin Pigmentation


Ocular Changes


Etiology

Other Adverse Reactions:
Note:

OVERDOSAGE

ADVERSE REACTIONS

Symptoms




Treatment





DOSAGE & ADMINISTRATION

ADULTS

























PEDIATRIC PATIENTS (6 months to 12 years of age)


Severe Behavioral Problems









HOW SUPPLIED













PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Chlorpromazine Hydrochloride

Chlorpromazine Hydrochloride

Chlorpromazine Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-830(NDC:0832-0304)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Chlorpromazine Hydrochloride CHLORPROMAZINE 200 mg

Inactive Ingredients

Ingredient Name Strength
ACACIA
FERROSOFERRIC OXIDE
CALCIUM SULFATE
carnauba wax
D&C YELLOW NO. 10
ALUMINUM OXIDE
FD&C BLUE NO. 2
FD&C YELLOW NO. 6
ANHYDROUS LACTOSE
MAGNESIUM STEARATE
METHYLPARABEN
SHELLAC
povidone
SODIUM BENZOATE
PROPYLPARABEN
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
brown 10 mm 832;200 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-830-24 200 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA084115 2011-08-16


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.